Scientific publications

Science, 2020

Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans

Arunachalam P., Wimmers F., Mok C. et al.

GSC Biological and Pharmaceutical Sciences, 2020

Susceptibility of men to SARS-CoV-2 may be caused by sex differences in ACE2 expression

Cell Reports Medicine, 2020

Systems-Level Immunomonitoring from Acute to Recovery Phase of Severe COVID-19

Rodriguez L., Pekkarinen P., Lakshmikanth T. et al.

Translational Psychiatry, 2020

Molecular linkage between post-traumatic stress disorder and cognitive impairment: a targeted proteomics study of World Trade Center responders

Kuan P., Clouston S., Yang X. et al.

Scientific Reports, 2020

Using proximity extension proteomics assay to discover novel biomarkers associated with circulating leptin levels in patients with type 2 diabetes

Vavruch C., Nowak C., Feldreich T. et al.

Analytical Biochemistry, 2020

The status of proteomics as we enter the 2020s: Towards personalised/precision medicine

Nice E.

American Journal of Reproductive Immunology, 2020

First‐trimester trophoblasts obtained by chorionic villus sampling maintain tolerogenic and proteomic features in successful pregnancies despite a history of unexplained recurrent pregnancy loss

Bruno V., Lindau R., Jenmalm M. et al.

Inflammatory Bowel Diseases, 2020

Salivary and Serum Inflammatory Profiles Reflect Different Aspects of Inflammatory Bowel Disease Activity

Majster M., Lira-Junior R., Höög C. et al.

Fluids and Barriers of the CNS, 2020

Location matters: highly divergent protein levels in samples from different CNS compartments in a clinical trial of rituximab for progressive MS

Bergman J., Svenningsson A., Liv P. et al.

Neuroendocrinology, 2020

A Plasma Protein Biomarker Strategy for Detection of Small Intestinal Neuroendocrine Tumors

Kjellman M., Knigge U., Welin S. et al.

European Heart Journal, 2020

Improved cardiovascular risk prediction using targeted plasma proteomics in primary prevention

Hoogeveen R., Pereira J., Nurmohamed N. et al.

Kidney International, 2020

A profile of multiple circulating tumor necrosis factor receptors associated with early progressive kidney decline in Type 1 Diabetes is similar to profiles in autoimmune disorders

Ihara K., Skupien J., Krolewski B. et al.

Scientific Reports, 2020

Identification of TNFAIP3 as relapse biomarker and potential therapeutic target for MOG antibody associated diseases

Saxena S., Lokhande H., Gombolay G. et al.

PLOS ONE, 2020

Inflammation, non-endothelial dependent coronary microvascular function and diastolic function—Are they linked?

Suhrs H., Schroder J., Bové K. et al.

Journal of Clinical Medicine, 2020

A Phase 2 Clinical Trial on the Use of Cibinetide for the Treatment of Diabetic Macular Edema

Lois N., Gardner E., McFarland M. et al.

Cell Reports, 2020

A Patient-Derived Cell Atlas Informs Precision Targeting of Glioblastoma

Johansson P., Krona C., Kundu S. et al.

Heart and Vessels, 2020

Elevated plasma endocan and BOC in heart failure patients decrease after heart transplantation in association with improved hemodynamics

Ahmed S., Ahmed A., Bouzina H. et al.

Genome Medicine, 2020

Multi-method genome- and epigenome-wide studies of inflammatory protein levels in healthy older adults

Hillary R., Trejo-Banos D., Kousathanas A. et al.

Journal of Internal Medicine, 2020

Use of proteomics to identify biomarkers associated with chronic kidney disease and long‐term outcomes in patients with myocardial infarction

Edfors R., Lindhagen L., Spaak J. et al.

Circulation, 2020

Genetic Associations With Plasma Angiotensin Converting Enzyme 2 Concentration

Nelson C., Sama I., Codd V. et al.